Fondation Maladies Rares Partner With Association VMOV for Call for Proposals on Growth Deficiency in Osteogenesis Imperfecta

Fondation Maladies Rares and Association VMOV have made funding available for projects researching growth deficiency caused by osteogenesis imperfecta. The call is open to researchers based in French academic institutions.

The Fondation Maladies Rares (Foundation for Rare Diseases) is a non-profit umbrella organisation created in 2012. Its overall mission is to promote, coordinate and support research on rare diseases to alleviate the social and therapeutic isolation of individuals afflicted with rare diseases and thus improve their daily life.

In partnership with the Association Vaincre la Maladie des Os de Verre (VMOV – Beat Brittle Bone Disease), Fondation Maladies Rares has launched a call for proposals to support biomedical research into osteogenesis imperfecta (commonly known as brittle bone disease) with a specific focus on growth deficiency linked to the disease. The programme intends to support any research that aims to develop understanding of the pathophysiological causes and mechanisms of growth deficiency in osteogenesis imperfecta patients, in addition to any research focused on therapeutic strategies. Innovative, transdisciplinary, basic or translational research projects. All disciplines within the domain of biomedical sciences are eligible.

The scientific lead of the project must be a researcher or enseignant-chercheur (teacher-researcher) holding a permanent position within a French research organisation.

Funding of up to €120,000 is available for a project with a maximum duration of 36 months. Funding may be used for temporary staff (except admin staff), equipment, operating costs, mission costs and service provision.

Applications must be submitted by 6 July 2023 (17:00 Paris Time).

(This report was the subject of a ResearchConnect Newsflash.)